NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its revenues for the second quarter increased 9 percent year over year, including 18 percent growth in its Human Health segment.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.
A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.
As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
The New York Times editorial board weighs in on scientific research misconduct.